Compare
agilon health, inc. vs Sotera Health Co vs Cryo Cell International Inc vs Marpai, Inc.
| Latest fiscal year | agilon health, inc. AGL | Sotera Health Co SHC | Cryo Cell International Inc CCEL | Marpai, Inc. MRAI |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-11-30 | 2025-12-31 |
| Revenue | $5.93B | $1.16B | $31.57M | $18.10M |
| Revenue growth (YoY) | -2.1% | +5.7% | -1.3% | -35.8% |
| Gross margin | n/a | 55.5% | 76.6% (computed) | n/a |
| Operating margin | -7.8% | n/a | 1.5% | -74.9% |
| Net margin | -6.6% | 6.7% | -7.7% | -91.5% |
| Net income | -$391.35M | $77.95M | -$2.43M | -$16.56M |
| EPS (Diluted) | n/a | $0.27 | -$0.30 | -$0.95 |
| Operating cash flow | -$105.76M | $287.19M | $5.48M | -$7.45M |
| Free cash flow | -$119.00M | $149.18M | $5.25M | n/a |
| Cash & equivalents | $173.71M | $344.62M | $319.0K | $133.0K |
| Total assets | $1.27B | $3.26B | $61.73M | $10.90M |
| Total liabilities | $1.14B | $2.66B | $80.33M | $43.47M |
| Shareholders' equity | $126.73M | $606.03M | -$18.61M | -$32.56M |
| Return on year-end equity | -308.8% | 12.9% | n/a | n/a |
| Shares outstanding | 414.73M | n/a | 8.06M | 24.04M |
Revenue, most recent five fiscal years
| Fiscal year | agilon health, inc. | Sotera Health Co | Cryo Cell International Inc | Marpai, Inc. |
|---|---|---|---|---|
| Latest | $5.93B Ended 2025-12-31 | $1.16B Ended 2025-12-31 | $31.57M Ended 2025-11-30 | $18.10M Ended 2025-12-31 |
| 1 year earlier | $6.06B Ended 2024-12-31 | $1.10B Ended 2024-12-31 | $31.99M Ended 2024-11-30 | $28.17M Ended 2024-12-31 |
| 2 years earlier | $4.32B Ended 2023-12-31 | $1.05B Ended 2023-12-31 | $31.34M Ended 2023-11-30 | $37.16M Ended 2023-12-31 |
| 3 years earlier | $2.39B Ended 2022-12-31 | $1.00B Ended 2022-12-31 | $30.34M Ended 2022-11-30 | n/a |
| 4 years earlier | $1.52B Ended 2021-12-31 | $931.48M Ended 2021-12-31 | $28.88M Ended 2021-11-30 | n/a |